Literature DB >> 9655

On the supersensitivity of dopamine receptors, induced by neuroleptics.

A V Christensen, B Fjalland, I M Nielsen.   

Abstract

Different neuroleptics caused dopamine receptor blockade (antagonism against methylphenidate-induced compulsive gnawing) for varying lengths of time. When the receptor blockade had expired, supersensitivity to dopamine agonists (occurrence of apomorphine-induced compulsive gnawing and enhancement of methylphenidate-induced gnawing) developed and persisted for varying periods of time. The degree and duration of supersensitivity was related to the degree and duration of the preceding receptor blockade. Inhibition of catecholamine or 5-HT synthesis had no influence on development of supersensitivity. Stimulation with a dopamine agonist, apomorphine, during the period of the development of supersensitivity did not modify the enhanced receptor supersensitivity. A cholinergic-dopaminergic balance was shown to be involved in the manifestation of compulsive behavior during the supersensitivity phase. Tolerance to the dopamine antagonistic effect of a neuroleptic also developed after a single neuroleptic treatment, most likely due to increased sensitivity of the receptors for the dopamine agonist. It is concluded, that the dopamine receptor blockade induced by a single dose of a neuroleptic agent is a dynamic phenomenon which in the course of time is replaced by an increased sensitivity of the receptors to dopamine agonists. Noradrenergic or 5-HT neuron systems do not seem to be involved in the neuroleptic-induced supersensitivity, whereas a dopaminergic-cholinergic balance is operative in the supersensitivity situation.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 9655     DOI: 10.1007/BF00423298

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  22 in total

1.  [Apomorphine synergism (inducedgnawing in mice) as a test for the differentiation of psychotropic substances].

Authors:  L THER; H SCHRAMM
Journal:  Arch Int Pharmacodyn Ther       Date:  1962-07-01

2.  Long-term effects of teflutixol on the synthesis and endogenous levels of mouse brain catecholamines.

Authors:  J Hyttel
Journal:  J Neurochem       Date:  1975-11       Impact factor: 5.372

3.  Amphetamine-induced dopaminergic hypersensitivity in guinea pigs. Implications in psychosis and human movement disorders.

Authors:  H L Klawans; D I Margolin
Journal:  Arch Gen Psychiatry       Date:  1975-06

4.  Behavioural supersensitivity to apomorphine following chronic treatment with drugs which interfere with the synaptic function of catecholamines.

Authors:  D Tarsy; R J Baldessarini
Journal:  Neuropharmacology       Date:  1974-11       Impact factor: 5.250

5.  Tolerance phenomena with neuroleptics catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol.

Authors:  H Asper; M Baggiolini; H R Burki; H Lauener; W Ruch; G Stille
Journal:  Eur J Pharmacol       Date:  1973-06       Impact factor: 4.432

6.  Enhancement of methylphenidate-induced stereotypies by repeated administration of neuroleptis.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

7.  Methylphenidate antagonism of haloperidol, interaction with cholinergic and anticholinergic drugs.

Authors:  B Fjalland; I Moller Nielsen
Journal:  Psychopharmacologia       Date:  1974-01-11

8.  Antagonism of methylphenidate-induced stereotyped gnawing in mice.

Authors:  V Pedersen; A V Christensen
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1972

9.  An experimental model of tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neural Transm       Date:  1972       Impact factor: 3.575

10.  Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.

Authors:  A C Sayers; H R Bürki; W Ruch; H Asper
Journal:  Psychopharmacologia       Date:  1975
View more
  25 in total

1.  Facilitation of self-stimulation of the prefrontal cortex in rats following chronic administration of spiroperidol or amphetamine.

Authors:  A Robertson; G J Mogenson
Journal:  Psychopharmacology (Berl)       Date:  1979-10       Impact factor: 4.530

2.  Receptor mechanisms in increased sensitivity to serotonin agonists after dihydroxytryptamine shown by electronic monitoring of muscle twitches in the rat.

Authors:  R M Stewart; A Campbell; G Sperk; R J Baldessarini
Journal:  Psychopharmacology (Berl)       Date:  1979-02-28       Impact factor: 4.530

3.  Tardive dyskinesia during and following treatment with haloperidol, haloperidol + biperiden, thioridazine, and clozapine.

Authors:  J Gerlach; H Simmelsgaard
Journal:  Psychopharmacology (Berl)       Date:  1978-10-31       Impact factor: 4.530

4.  Dopamine-receptor binding and adenylate-cyclase activity in mouse striatal tissue in the supersensitivity phase after neuroleptic treatment.

Authors:  J Hyttel
Journal:  Psychopharmacology (Berl)       Date:  1978-12-08       Impact factor: 4.530

Review 5.  Dopaminergic supersensitivity after neuroleptics: time-course and specificity.

Authors:  P Muller; P Seeman
Journal:  Psychopharmacology (Berl)       Date:  1978-12-15       Impact factor: 4.530

6.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

7.  Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin.

Authors:  M Valchár; J Metysová; J Chlebounová; A Dlabac
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

8.  Levodopa and receptor sensitivity modification in tardive dyskinesia.

Authors:  D E Casey; J Gerlach; N Bjørndal
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 9.  Pharmacodynamic effects and possible therapeutic uses of THIP, a specific GABA-agonist.

Authors:  A V Christensen; O Svendsen; P Krogsgaard-Larsen
Journal:  Pharm Weekbl Sci       Date:  1982-10-22

10.  Tolerance to fluphenazine and supersensitivity to apomorphine in central dopaminergic systems after chronic fluphenazine decanoate treatment.

Authors:  S C Wheeler; R H Roth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-06       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.